331 related articles for article (PubMed ID: 35411083)
21. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
[TBL] [Abstract][Full Text] [Related]
22. A complex epigenome-splicing crosstalk governs epithelial-to-mesenchymal transition in metastasis and brain development.
Sahu SK; Agirre E; Inayatullah M; Mahesh A; Tiwari N; Lavin DP; Singh A; Strand S; Diken M; Luco RF; Belmonte JCI; Tiwari VK
Nat Cell Biol; 2022 Aug; 24(8):1265-1277. PubMed ID: 35941369
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
24. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
25. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
26. Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
Loo SY; Hirpara JL; Pandey V; Tan TZ; Yap CT; Lobie PE; Thiery JP; Goh BC; Pervaiz S; Clément MV; Kumar AP
Antioxid Redox Signal; 2016 Aug; 25(6):283-99. PubMed ID: 27400860
[TBL] [Abstract][Full Text] [Related]
27. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
[TBL] [Abstract][Full Text] [Related]
28. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
29. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells.
Nickel A; Stadler SC
Transl Res; 2015 Jan; 165(1):126-42. PubMed ID: 24768944
[TBL] [Abstract][Full Text] [Related]
30. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
31. EMT as the ultimate survival mechanism of cancer cells.
Tiwari N; Gheldof A; Tatari M; Christofori G
Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-mesenchymal transition in tumor metastasis.
Yeung KT; Yang J
Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
[TBL] [Abstract][Full Text] [Related]
33. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.
Gallardo A; Molina A; Asenjo HG; Lopez-Onieva L; Martorell-Marugán J; Espinosa-Martinez M; Griñan-Lison C; Alvarez-Perez JC; Cara FE; Navarro-Marchal SA; Carmona-Sáez P; Medina PP; Marchal JA; Granados-Principal S; Sánchez-Pozo A; Landeira D
Oncogene; 2022 Jul; 41(28):3611-3624. PubMed ID: 35680984
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
35. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
36. USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis.
Garcia DA; Baek C; Estrada MV; Tysl T; Bennett EJ; Yang J; Chang JT
Mol Cancer Res; 2018 Jul; 16(7):1172-1184. PubMed ID: 29724812
[TBL] [Abstract][Full Text] [Related]
37. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
38. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
Punzi S; Balestrieri C; D'Alesio C; Bossi D; Dellino GI; Gatti E; Pruneri G; Criscitiello C; Lovati G; Meliksetyan M; Carugo A; Curigliano G; Natoli G; Pelicci PG; Lanfrancone L
Breast Cancer Res; 2019 Nov; 21(1):123. PubMed ID: 31752957
[TBL] [Abstract][Full Text] [Related]
39. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
Yang M; Ma B; Shao H; Clark AM; Wells A
BMC Cancer; 2016 Jul; 16():419. PubMed ID: 27387344
[TBL] [Abstract][Full Text] [Related]
40. Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal Transition.
Katipally RR; Pitroda SP; Weichselbaum RR; Hellman S
Clin Cancer Res; 2023 Aug; 29(15):2761-2766. PubMed ID: 37115507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
